Fabrice Chouraqui
Tracked across 2 events · 12 articles · First seen Apr 07, 2026 · Last active Aug 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Fabrice Chouraqui, CEO of Pharming Group, will present at the Needham Virtual Healthcare Conference, representing the company to investors.
Apr 07, 2026 · 6 articles
Regulatory
Levi & Korsinsky, a securities litigation firm, has commenced an investigation into Pharming Group N.V. (NASDAQ: PHAR) concerning potential violations of federal securities laws. The investigation follows a 22% drop in Pharming's stock on July…
Impact: As CEO, Fabrice Chouraqui made statements on a November 2025 earnings call downplaying competition for RUCONEST, which are now under scrutiny in the investigation. His statements could be central to allegations of inadequate disclosure.
Jul 31, 2026 · 6 articles
50
Fabrice Chouraqui made statementsPharming Group Securities...
ERGEN INTELLIGENCE
Track Fabrice Chouraqui live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard